NCT00644553View on ClinicalTrials.gov

Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis

PHASE3CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

March 31, 2004

Conditions
Acute Bacterial Sinusitis (ABS)
Interventions
DRUG

Clarithromycin

Clarithromycin Extended-Release 500 mg tablet (2 tablets QD)

DRUG

Amoxicillin

Amoxicillin-clavulanate 875/125 mg tablet (1 tablet BID)

Trial Locations (53)

11522

Athens

16132

Genova

18454

Piraeus

26500

Pátrai

27100

Pavia

28210

Charlotte

28805

Madrid

35128

Padua

35235

Birmingham

37601

Johnson City

43235

Columbus

47002

Valladolid

54636

Thessaloniki

56430

Thessaloniki

78209

San Antonio

83814

Coeur d'Alene

85014

Phoenix

90127

Palermo

92037

La Jolla

93405

San Luis Obispo

93611

Clovis

95124

Catania

97404

Eugene

99216

Spokane

762631

Bucharest

773511

Bucharest

N2C 2N9

Kitchener

M9W 4L6

Toronto

J1J 2B8

Sherbrooke

S7H 0W6

Saskatoon

115 27

Athens

H-1062

Budapest

H-1096

Budapest

H-1097

Budapest

H-1106

Budapest

H-3100

Salgótarján

H-9700

Szombathely

H-8200

Veszprém

LT-3007

Kaunas

LT-2014

Vilnius

LT-2021

Vilnius

LT-2025

Vilnius

15-276

Bialystok

43-300

Bielsko-Biala

85-090

Bydgoszcz

44-100

Gliwice

58-506

Jelenia Góra

20-954

Lublin

50-368

Wroclaw

51-124

Wroclaw

06010

Badajoz

08036

Barcelona

07014

Palma de Mallorca

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY